Longevity Research

{
  "result": " This tick, the Gonka Labs swarm narrowed its aperture to a single, high-resolution question in the mTORC1–autophagy–inflammaging axis: does genetically predicted abundance of the mTORC1 regulators *RPTOR* and *TSC2* causally influence systemic inflammation, as measured by IL-6 and hs-CRP? Rather than casting a wide net, the mission designed three tightly convergent workstreams: (1) colocalized two-sample Mendelian randomization using cis-pQTL instruments from large proteomics biobanks (UKB-PPP, deCODE) to test whether *RPTOR* and *TSC2* protein variants share causal genetic architecture with inflammatory biomarkers; (2) human macrophage perturbation of *RPTOR* and *TSC2* coupled to TFEB/TFE3 and NF-κB p65(RelA) readouts; and (3) autophagy flux mediation through SQSTM1/p62 turnover, including a two-step mediation MR framework. All broader cytokines, non-human models, and downstream longevity outcomes were deliberately deprioritized to prevent scope creep and maximize the odds of validating one clean causal edge.\n\nThe biological premise is that mTORC1 acts as a cellular nutrient sensor that, when chronically overactive, suppresses autophagy—the lysosomal recycling program that clears damaged proteins and organelles. The hypothesis under test posits that impaired autophagic flux causes accumulation of the adaptor protein SQSTM1/p62, which in turn sustains NF-κB signaling and drives IL-6 production, a central mediator of age-related chronic inflammation (“inflammaging”). By modulating *RPTOR* and *TSC2*—the molecular throttle and brake on mTORC1, respectively—the swarm aims to determine whether restoring autophagic recycling in human macrophages can break this inflammatory circuit before it amplifies into circulating cytokines.\n\nEvidence strength this cycle is limited to theoretical scaffolding. The tick generated **zero new empirical findings** and **zero relations** in the knowledge graph, though the entity store grew to 127 nodes and five hypotheses were refined. Recent literature additions provide review-level context on aging, metabolic disease, cellular senescence, and atherosclerosis, but they do not establish the directed causal edge from mTORC1 sensing to IL-6 via autophagy. No human genetic colocalization, primary cell perturbation, or flux data were extracted or produced in this iteration. Consequently, the hypothesis remains at the in silico design stage: biologically plausible and precisely framed, but entirely unvalidated by human, animal, or in vitro evidence.\n\nOutstanding questions dominate the next-tick agenda. First, can cis-pQTLs for *RPTOR* and *TSC2* demonstrate colocalization with IL-6 or hs-CRP GWAS signals at the stringent posterior probability threshold (>0.8), or will linkage disequilibrium confounding sever the predicted link? Second, does any existing primary human macrophage or iPSC-derived model data already show that allele-specific or CRISPR-mediated modulation of *RPTOR*/*TSC2* shifts TFEB/TFE3 nuclear localization and dampens phospho-p65? Third, is SQSTM1/p62 turnover a statistical and mechanistic mediator in human populations, or is the mTORC1–inflammation relationship driven by parallel pathways? The swarm will prioritize mining published proteogenetic and flux experiments to answer these before recommending any translational step.\n\nOverall confidence in the *biological direction* is moderate: the mTORC1–autophagy–NF-κB nexus is well-documented in broader aging research. However, confidence in the *specific causal edge* tested here—*RPTOR*/*TSC2* protein abundance → autophagy flux → IL-6/hs-CRP in humans—is currently low, precisely because the knowledge graph contains no relations and no findings were secured this tick. The strategy’s rigor lies in its restraint; by refusing to speculate beyond the IL-6/hs-CRP dyad, the mission accepts a narrower field of view in exchange for mechanistic clarity. Key limitations include the exclusion of tissue-specific effects, sex-specific genetic architectures, and the broader inflammaging milieu (IL-1β, TNF-α, MCP-1), any of which could modify or override the signal under study.\n\n*These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 5
}